Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

1.5K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

4.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.8K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

3.0K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
3.0K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Anxiety: Overview01:18

Anxiety: Overview

1.3K
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
1.3K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

4.0K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mice produce interneurons in the septum as a response to aversive experiences and antidepressant treatment.

Science advances·2026
Same author

Prefrontal neural geometry of learned cues guides motivated behaviours.

Nature·2026
Same author

Axon initial segment dynamics during associative fear learning.

Nature neuroscience·2025
Same author

Heterogeneous plasticity of amygdala interneurons in associative learning and extinction.

Nature communications·2025
Same author

From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis.

European journal of medical research·2025
Same author

Native Australian plants to combat oral health-related pathogens.

Microbiological research·2025
Same journal

Connectomic evidence that ordered activity drives neuromuscular network formation.

Nature neuroscience·2026
Same journal

Noninvasive decoding of typed sentences from human brain activity.

Nature neuroscience·2026
Same journal

Striatal control of amygdalar acetylcholine release during salience-associated processing.

Nature neuroscience·2026
Same journal

Mitochondrial stress response drives microglial senescence.

Nature neuroscience·2026
Same journal

Conditioned accumbal dopamine transients forecast individual preference for drug versus natural rewards and compulsive behavior.

Nature neuroscience·2026
Same journal

The mitochondrial unfolded protein response in human microglia disrupts neuronal-glial communication and promotes senescence.

Nature neuroscience·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

20.5K

Regulating anxiety with extrasynaptic inhibition.

Paolo Botta1,2, Lynda Demmou1,2, Yu Kasugai3

  • 1Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Nature Neuroscience
|September 1, 2015
PubMed
Summary
This summary is machine-generated.

Aversive experiences increase anxiety by altering specific central amygdala neurons. Researchers identified protein kinase C delta (PKCδ) neurons as key to anxiety and fear generalization, revealing novel therapeutic targets.

More Related Videos

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

33.1K
Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

5.9K

Related Experiment Videos

Last Updated: Apr 4, 2026

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

20.5K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

33.1K
Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

5.9K

Area of Science:

  • Neuroscience
  • Behavioral Science
  • Molecular Biology

Background:

  • Aversive experiences can cause anxiety and fear generalization, but the underlying neural mechanisms are not fully understood.
  • Identifying specific neuronal populations involved in these maladaptive changes is crucial for understanding anxiety disorders.

Purpose of the Study:

  • To identify the specific neuronal subpopulations in the central amygdala that control anxiety.
  • To elucidate the mechanisms by which aversive experiences alter neuronal activity and lead to anxiety and fear generalization.

Main Methods:

  • Behavioral analysis in mice to assess anxiety and fear generalization.
  • Physiological recordings to measure neuronal activity.
  • Optogenetic techniques to manipulate specific neuronal populations.
  • Molecular analysis to identify key proteins involved in neuronal regulation.

Main Results:

  • A specific subpopulation of central amygdala neurons expressing protein kinase C delta (PKCδ) was identified as critical for controlling anxiety.
  • Aversive experiences were shown to induce anxiety and fear generalization by regulating the activity of PKCδ(+) neurons.
  • Extrasynaptic inhibition mediated by α5 subunit-containing GABAA receptors was found to be the mechanism regulating PKCδ(+) neuron activity.
  • The study revealed an overlap in neuronal circuits mediating fear and anxiety at the level of defined central amygdala neuron subpopulations.

Conclusions:

  • The findings identify PKCδ(+) central amygdala neurons as key players in anxiety and fear generalization.
  • Persistent changes in the excitability of this specific cell type can orchestrate complex behavioral changes, offering potential therapeutic targets.
  • The study highlights the overlap between fear and anxiety circuits and the role of specific neuronal subpopulations in mediating these behaviors.